Physician profile
Aurora Pryor
NPI 1336223221
$124,801.61
in general payments reported to CMS, 2019-2025
18 companies · $5,977 in 2025
The $5,977 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,171 · 2020: $16K · 2021: $27K · 2022: $18K · 2023: $37K · 2024: $18K · 2025: $5,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,405 · Travel and Lodging: $3,816 · Food and Beverage: $3,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,998.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,405.00 |
| Travel and Lodging | $3,816.44 |
| Food and Beverage | $3,636.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $37,204.12 | 2021-2025 | Ligasure, Signia, Sonicision |
| Stryker Corporation | $34,404.26 | 2020-2025 | Spy-Phi System, 1688, S3 |
| W. L. Gore & Associates, INC. | $34,230.84 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Medical Device Business Services, INC. | $9,159.12 | 2020-2024 | |
| Covidien LP | $4,542.48 | 2019-2020 | |
| Intuitive Surgical, INC. | $2,660.01 | 2021-2022 | |
| Regeneron Pharmaceuticals, INC. | $948.00 | 2024 | |
| Applied Medical Resources Corporation | $750.00 | 2023-2025 | |
| Intra-Sana Laboratories | $194.25 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Novo Nordisk INC | $146.50 | 2019-2023 | Wegovy |
| Olympus America INC. | $140.00 | 2019 | |
| Boston Scientific Corporation | $133.96 | 2019-2024 | Spyglass Discover |
| Ethicon US, LLC | $93.48 | 2022 | |
| Innocoll Pharmaceuticals Limited | $58.32 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.59 | 2023 | Gattex |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $33.72 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $32.73 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.23 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aurora Pryor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.